[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections]

Nihon Rinsho. 2002 Feb:60 Suppl 2:455-9.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Abietanes*
  • Amoxicillin / administration & dosage*
  • Anti-Ulcer Agents / administration & dosage*
  • Anti-Ulcer Agents / pharmacology
  • Clarithromycin
  • Clinical Trials as Topic
  • Diterpenes / administration & dosage*
  • Diterpenes / pharmacology
  • Drug Administration Schedule
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Enzyme Inhibitors / administration & dosage*
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / microbiology
  • Helicobacter pylori* / drug effects
  • Humans
  • Lansoprazole
  • Omeprazole / administration & dosage*
  • Omeprazole / analogs & derivatives*
  • Proton Pump Inhibitors*
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Abietanes
  • Anti-Ulcer Agents
  • Diterpenes
  • Enzyme Inhibitors
  • Proton Pump Inhibitors
  • Lansoprazole
  • ecabet
  • Amoxicillin
  • Clarithromycin
  • Omeprazole